<code id='7B60734A3F'></code><style id='7B60734A3F'></style>
    • <acronym id='7B60734A3F'></acronym>
      <center id='7B60734A3F'><center id='7B60734A3F'><tfoot id='7B60734A3F'></tfoot></center><abbr id='7B60734A3F'><dir id='7B60734A3F'><tfoot id='7B60734A3F'></tfoot><noframes id='7B60734A3F'>

    • <optgroup id='7B60734A3F'><strike id='7B60734A3F'><sup id='7B60734A3F'></sup></strike><code id='7B60734A3F'></code></optgroup>
        1. <b id='7B60734A3F'><label id='7B60734A3F'><select id='7B60734A3F'><dt id='7B60734A3F'><span id='7B60734A3F'></span></dt></select></label></b><u id='7B60734A3F'></u>
          <i id='7B60734A3F'><strike id='7B60734A3F'><tt id='7B60734A3F'><pre id='7B60734A3F'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:focus    Page View:74
          Cigna Healthcare's logo on a phone
          Adobe

          CVS Health viewed Amy Bricker as a potential CEO. But she won’t be going to the health care conglomerate anytime soon.

          A federal appeals court has ruled Bricker, a former high-ranking executive at Cigna, cannot jump to CVS because it would violate her noncompete agreement that she signed while at Cigna. The appeals court’s decision backs up what a district court had previously ruled.

          advertisement

          The case is a prominent example of why the health care industry, and corporate America writ large, does not want noncompetes to go away. In April, the Federal Trade Commission approved a nationwide ban on most such agreements, which prevent workers from moving to other jobs, but companies and corporate lobbying groups have already sued to squash the ban.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more
          Goldman Sachs launches $650M fund for life science investments
          Goldman Sachs launches $650M fund for life science investments

          AdobeInvestmentbankGoldmanSachsisjumpingintothebiotechworldafterraising$650milliontoinvestinprivatel

          read more
          Affirmative action in medical school literally saved lives
          Affirmative action in medical school literally saved lives

          AdobeThepastseveralmonthshavebeengrimforhealthintheU.S.InDecember,theCentersforDiseaseControlandPrev

          read more

          JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

          InhonorofJPMWeek,you’rereadingaspecialeditionofourbiotechnewsletter,TheReadout.Tostayontopofthelates